For example, miR-543 was shown to impair tumor growth and proliferation in breast cancer cell lines (MCF-7, MDA-MB-231, MDA-MB-453, HCC-1937) by inhibiting ERK2 activity [51]. Here, MAPK1 is linked to breast carcinoma.